KTTA·70261F202·US·equity·Healthcare - Biotechnology-13D/G
KTTA (PASITHEA THERAPEUTICS CORP) is held by 10 institutional investors as of Q1 2026. Largest holders: JANUS HENDERSON GROUP PLC ($1.6M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($1.6M), AMERIPRISE FINANCIAL INC ($1M). Net institutional sentiment: Mixed.
See how KTTA's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer